Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 22, 2004
(November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the...
-
Nov 18, 2004
(November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes...
-
Nov 16, 2004
(November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a...
-
Nov 15, 2004
(November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration...
-
Nov 12, 2004
(November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in...
-
Nov 8, 2004Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant
(November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its...
-
Nov 5, 2004
(November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at...
-
Nov 4, 2004
(November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...